Navigation Links
Abbott Statement on the Results of the AIM-HIGH Study Presented at AHA 2011
Date:11/15/2011

statins for more than a year, many for more than five years.  In these patients, although baseline HDL cholesterol levels were low (35 mg/dL), they had LDL cholesterol levels of 71 mg/dL, non-HDL cholesterol levels of 106 mg/dL and triglycerides of 161 mg/dL.

The results from the AIM-HIGH study should not be applied beyond the patient population studied. The 3,414 patients in the AIM-HIGH study represent a small percentage of high-risk patients who reach their guideline-recommended lipid treatment goals and are not representative of the typical patient being treated for lipid disorders in clinical practice today.  

"Niaspan remains an important treatment option to help patients reach their lipid treatment goals, many of whom require multiple medications to do so. Even when looking only at the high-risk patient group evaluated in the AIM-HIGH study, epidemiologic data tell us that in clinical practice more than three-quarters of these patients do not reach their recommended goals for lipid therapy," said John Leonard, M.D., senior vice president, Global Pharmaceutical Research and Development, Abbott. "Physicians should consider each patient's cardiovascular profile and the NCEP treatment guidelines when evaluating a patient for potential additional treatment with lipid lowering medicines such as Niaspan."  

In the interim data, an unexpected imbalance in ischemic stroke events in patients who received Niaspan and simvastatin as compared to simvastatin was identified. The final data showed that the difference in ischemic stroke events between the two study arms was not statistically significant. Previous studies, meta-analyses and post-marketing safety data also did not show any stroke safety signals related to niacin or Niaspan.  

The findings from the AIM-HIGH study were presented at the American Heart Association Scientific Sessions 2011 and were simultaneously published online in the New England Journal of Medic
'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Abbott Honored With Scrip Award for Leadership in Corporate Social Responsibility
2. PATH, Abbott and the Abbott Fund Form Innovative Partnership to Prevent Malnutrition
3. Perrigo Confirms Filing for Testosterone Gel 1.0% and Announcement of Patent Infringement Lawsuit by Abbott
4. Experts Report that Abbotts New PLEX-ID Assay Offers Important Testing Capabilities for Biothreat Defense
5. Abbott Awards CFCareForward Scholarships to Two Students Living With Cystic Fibrosis Pursuing Undergraduate and Graduate Degrees
6. Abbotts Genetic Test for Acute Myeloid Leukemia Prognosis Cleared by FDA
7. Abbott Honored With Asian CSR Award for Leadership in Science Education
8. Neurocrine Biosciences Receives Second Milestone Payment of $20 Million Under Abbott Collaboration Agreement
9. Zacks Industry Outlook Highlights: Vertex Pharma, AstraZeneca, Abbott Labs, Allergan and Onyx Pharmaceuticals
10. Abbott Receives CE Mark for Healon EndoCoat Protective Gel for Cataract Surgery
11. Abbott Expanding Manufacturing Capacity in China to Meet Demands of Fast-Growing Nutrition Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... /PRNewswire-iReach/ -- Asthma is a chronic inflammatory lung ... most commonly starts in childhood. It is a ... airways, leading to airflow limitation and airway hyper-responsiveness ... endogenous and exogenous irritants. Exposure to irritants instigates ... the airways, tightening of the respiratory muscles, and ...
(Date:9/15/2014)... , Sept. 15, 2014  Valeant Pharmaceuticals International, Inc. ... its wholly owned subsidiary, Valeant Pharmaceuticals International, will redeem ... of its 6.75% Senior Notes due 2017, CUSIP Nos. ... 2014 and has mailed an irrevocable notice of redemption ... a copy of the irrevocable notice of redemption with ...
(Date:9/15/2014)... 15, 2014  Decision Resources Group,s new ... finds that online information and other value-added ... differentiate their offering and support physicians. Physicians ... decisions rely on websites, mobile apps and ... these physicians are looking to manufacturers to ...
Breaking Medicine Technology:Asthma Market to Reach 161.02 million Cases in 10MM by 2023 2Asthma Market to Reach 161.02 million Cases in 10MM by 2023 3Asthma Market to Reach 161.02 million Cases in 10MM by 2023 4Asthma Market to Reach 161.02 million Cases in 10MM by 2023 5Valeant Announces Redemption of All of the Outstanding $500.0 Million Aggregate Principal Amount of its 6.75% Senior Notes due 2017 2Physician device decision-makers show strong demand for device manufacturer digital content and support 2Physician device decision-makers show strong demand for device manufacturer digital content and support 3
... Oct. 28 Thoratec Corporation (Nasdaq: THOR ... therapies to save, support and restore failing hearts, said ... 2010 increased 40 percent versus the third quarter of ... the third quarter and first nine months of 2010 ...
... Oct. 28 As part of its continued commitment ... CTIA–The Wireless Association® today announced that it is hosting ... World Forum for Medicine and International Trade Fair and ... mobile products, applications and network management solutions focused on ...
Cached Medicine Technology:Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 2Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 3Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 4Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 5Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 6Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 7Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 8Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 9Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 10Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 11Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 12Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 13Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 14Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 15Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations 16CTIA-The Wireless Association® to Host First Wireless Health Pavilion at MEDICA 2010 World Forum for Medicine 2CTIA-The Wireless Association® to Host First Wireless Health Pavilion at MEDICA 2010 World Forum for Medicine 3
(Date:9/16/2014)... Synergy Research Group has debuted the Ukraine Orange ... and analysis of the state of clinical trials in ... including Ministry of Health in Ukraine and the FDA, ... intelligence on clinical trials in the country. , The ... local and international life science and business community involved ...
(Date:9/16/2014)... 16, 2014 Washington Valley Cellars and ... 30th issue of Wine Spectator magazine. This feature is ... and a great honor for the company as a ... constructing custom wine cellars and providing wine storage solutions ... has constructed over 500 wine cellars across the country, ...
(Date:9/16/2014)... small serve of dairy food may reduce the risk ... such foods have not traditionally formed part of the ... led by Emeritus Professor Mark Wahlqvist from Monash University,s ... Asia Institute, considered the role increased consumption of dairy ... and longevity. , "In a dominantly Chinese food ...
(Date:9/16/2014)... positron emission tomography (PET) tracer is effective in diagnosing ... according to a case study conducted at the Icahn ... Neuroimaging (MNI) LLC in New Haven, and published September ... Specifically, the study results suggest that an experimental radiolabeled ... onto a protein called tau that accumulates in the ...
(Date:9/16/2014)... international analysis of patients with stage IV non-small cell ... (OS) rate can be related to factors including the ... and that aggressive treatment for "low-risk" patients leads to ... research presented today at the American Society for Radiation ... cancer has spread from an original tumor to other ...
Breaking Medicine News(10 mins):Health News:Synergy Research Group Debuts Ukraine Orange Paper 2Health News:Washington Valley Cellars Featured in September Issue of Wine Spectator 2Health News:A heart-felt need for dairy food 2Health News:Neuroimaging technique identifies concussion-related brain disease in living brain 2Health News:Neuroimaging technique identifies concussion-related brain disease in living brain 3Health News:Select group of stage IV lung cancer patients achieve long-term survival after aggressive treatments 2Health News:Select group of stage IV lung cancer patients achieve long-term survival after aggressive treatments 3Health News:Select group of stage IV lung cancer patients achieve long-term survival after aggressive treatments 4
... of inappropriate shocks from appliances have been reported ... literally shocking tale of the potential dangers of ... comes from cardiologists in Denmark. , "We recently ... implantable cardioverter defibrillator, was readmitted shortly after hospital ...
... Bipartisan Group Led by Former Rep. Gephardt Underscores ... Finding Cures for Life-Threatening Diseases , WASHINGTON, March ... applauds President Obama on his support for improving ... costs through continued scientific and technological advancements. (Logo: ...
... prevents Honolulu residents from implementing ... 25 Taking Control of Your Diabetes (TCOYD) announced ... research firm Yankelovich that found that although Honolulu residents ... about diabetes management than the majority of their peers ...
... N.J., March 25 The Christopher & Dana Reeve ... and treatments for spinal cord injuries and improving the ... States House of Representatives for passing the Christopher and ... 146, the Omnibus Public Land Management Act. The legislation ...
... reports a more powerful immune response than from an injection ... nicer it would be to get vaccinated by drinking a ... , That might someday be the case, thanks to Northwestern ... which are healthy bacteria found in dairy products such as ...
... Data provided by nonprofit organization, Consumers, CheckbookMILWAUKEE, March ... the world,s largest-circulation magazine with more than ... map listing the top-ranked hospitals in the U.S. ... Luke,s Medical Center was one of two ...
Cached Medicine News:Health News:Faulty Household Wiring Can Trigger a Heart Defibrillator 2Health News:Council for American Medical Innovation Applauds President Obama for Calling for 'Serious Investments in Science and Technology' 2Health News:Survey Reveals Honolulu Residents Perceive Financial Challenges as Main Barrier in Properly Managing Their Type 2 Diabetes 2Health News:Survey Reveals Honolulu Residents Perceive Financial Challenges as Main Barrier in Properly Managing Their Type 2 Diabetes 3Health News:Survey Reveals Honolulu Residents Perceive Financial Challenges as Main Barrier in Properly Managing Their Type 2 Diabetes 4Health News:Christopher & Dana Reeve Foundation Applauds Historic Passage of the Christopher and Dana Reeve Paralysis Act 2Health News:Christopher & Dana Reeve Foundation Applauds Historic Passage of the Christopher and Dana Reeve Paralysis Act 3Health News:Oral Yogurt 'Vaccine' Could Blunt Ouch Factor 2Health News:AARP Magazine Lists Aurora St. Luke's Medical Center Among the 126 Best Hospitals in the United States 2
Designed for peeling delicate epiretinal membrane in cases of premacular fibroplasia. Positive action closure. Barrel design with straight 20 gauge 40 gauge long shaft. 1 x 1.5 mm lightly serrated ja...
Triangular shaped tips. Marked for 5 mm and 10 mm tucks. Round knurled handle with polished finish....
Angled shafts with 9 mm scaled jaws. 1 mm teeth on one jaw fit into holes on the other jaw. Slide lock and serrated handle with polished finish. Left....
Shafts angled 45 degrees, 10 mm from tip to bend. Tips curved with 0.5 mm, 1 x 2 teeth. Serrated handle with polished finish....
Medicine Products: